Indication of naphtho[2,3-F]quinoxaline-7,12-dione compound in alleviating pain
US9284281B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2014 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Oct 23, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D241/42
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are naphtho[2,3-f]quinoxaline compounds and pharmaceutical composition thereof. The compounds of the invention have been demonstrated as having analgesic effects and therefore may be applicable for use as a novel agent in relieving acute or chronic pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.